hotspot -WSS

hotspot

author：hotspot 2025-10-02 22:27:25 - browse：84225

Adam's take main illustration — Molly Ferguson/STAT

Thoughts about Cytokinetics after Wednesday night’s financing announcement:

1. Management is raising $500 million at $51 per share, when the stock was at $45 per share before the aficamtem study readout in December. That’s shocking. Somehow, management has not only removed all the M&A premium from the stock, but much or most of aficamtem’s value, too.

2. Omecamtiv’s resurrection: Are you kidding me? No one thinks bringing back this heart failure drug is a good idea, except management. Making it worse, the terms of the Royalty Pharma loan are, again, shocking. All the risk is borne by Cytokinetics. Royalty, in fact, may do better if omecamtiv fails.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： 'Brian's Song' at 50 still offers lessons about cancer for today

focus

WSS

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Doctors are clamoring for more clarity on Paxlovid prescribing

Statins may not be needed by millions of people, study suggests

Judge in Trump's classified documents case questions use of out

Medical device trials still don't enroll enough women, study finds

How CRISPR works, explained in two minutes

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Election results set back Medicaid expansion plans

Hollywood unions extend contract negotiations for actors

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Report captures long Covid’s disabling effects and policy challenges

Guidelines to prevent youth baseball injuries need more muscle

Study: Why relieving medical debt did not improve financial outcomes

ChatGPT in medicine: STAT answers readers' burning questions

St. Louis police protesters begin picking up checks in $4.9 million settlement

Wikipedia

Lilly's Alzheimer's drug donanemab backed by FDA advisers

St. Louis police protesters begin picking up checks in $4.9 million settlement

Report captures long Covid’s disabling effects and policy challenges

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

focus

entertainment

knowledge

focus